𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: Report of clinical and biochemical findings in four patients and treatment in one patient

✍ Scribed by Irons, Mira ;Elias, Ellen Roy ;Tint, G. S. ;Salen, Gerald ;Frieden, Roger ;Buie, Timothy M. ;Ampola, Mary


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
630 KB
Volume
50
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

✦ Synopsis


We report on four patients with the Smith-Lemli-Opitz (SLO) syndrome who appear to have a defect in cholesterol biosynthesis. The initial results of therapy of one of the patients with cholesterol and bile acids to correct her metabolic abnormalities are described. This finding provides a biochemical marker to help in the diagnosis of this syndrome, may provide insight into the pathogenesis of this disorder, and have therapeutic and prenatal diagnostic implications as well.


πŸ“œ SIMILAR VOLUMES


Clinical and biochemical spectrum of pat
✍ Cunniff, Christopher; Kratz, Lisa E.; Moser, Ann; Natowicz, Marvin R.; Kelley, R πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 2 views

RSH/Smith-Lemli-Opitz (RSH/SLO) syndrome is an autosomal recessive malformation syndrome recently shown to be associated with a severe deficiency of cholesterol biosynthesis and markedly elevated plasma and tissue levels of 7-dehydrocholesterol (7-DHC), the immediate precursor of cholesterol in the

Clinical effects of cholesterol suppleme
✍ Elias, Ellen R.; Irons, Mira B.; Hurley, Anne D.; Tint, G. Stephen; Salen, Geral πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views

We describe the clinical effects of cholesterol supplementation in 6 children with the RSH-"Smith-Lemli-Opitz" syndrome (SLOS). The children ranged in age from birth to 11 years at the onset of therapy, with pretreatment cholesterol levels ranging from 8 to 62 mg/dl. Clinical benefits of therapy wer

Holoprosencephaly in RSH/Smith-Lemli-Opi
✍ Kelley, Richard I.; Roessler, Erich; Hennekam, Raoul C. M.; Feldman, Gerald L.; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 724 KB

The RSH/Smith-Lemli-Opitz syndrome (RSH/SLOS) is an autosomal recessive malformation syndrome associated with increased levels of 7-dehydrocholesterol (7-DHC) and a defect of cholesterol biosynthesis at the level of 3B-hydroxy-steroid-A'reductase (7-DHC reductase). Because rats exposed to inhibitors

Screening for abnormal cholesterol biosy
✍ Honda, Akira; Batta, Ashok K.; Salen, Gerald; Tint, G. Stephen; Chen, Thomas S.; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

The Smith-Lemli-Opitz syndrome (SLOS) is a common condition caused by deficiency of 7-dehydrocholesterol ⌬ 7 -reductase. The syndrome can usually be diagnosed by demonstrating markedly increased plasma concentrations of the cholesterol precursor, 7-dehydrocholesterol. We describe a simple and rapid